Log In
BCIQ
Print this Print this
 

Horizant, gabapentin enacarbil (Regnite) (GSK1838262, XP13512)

Also known as: Solzira (1838262) (ASP8825)

  Manage Alerts
Collapse Summary General Information
Company XenoPort Inc.
DescriptionExtended-release prodrug of gabapentin
Molecular Target Calcium channel N-type
Mechanism of ActionN-type (Cav2.2) calcium channel modulator
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$145.0M

$20.0M

$120.0M


 Deals Details
Get a free BioCentury trial today